Lps-induced systemic inflammation does not alter atherosclerotic plaque area or inflammation in ApoE3*Leiden mice in the early phase up to 15 days

Shock

Volumn 50, Issue 3, 2018, Pages 360-365

  Fuijkschot, Wessel W ^a,b   Morrison, Martine C ^c   Zethof, Ilse P A ^a   Krijnen, Paul A J ^b   Kleemann, Robert ^c   Niessen, Hans W M ^a,b   Smulders, Yvo M ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TNO   (Netherlands)

Author keywords

Animal models of human disease; Atherosclerosis; Inflammation; Myocardial infarction; Sepsis

Indexed keywords

APOLIPOPROTEIN E3; LIPOPOLYSACCHARIDE; SERUM AMYLOID A; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTIC ROOT; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY WEIGHT LOSS; CELL DENSITY; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; INFLAMMATORY CELL; LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION; LYMPHOCYTE; MACROPHAGE; MOUSE; NONHUMAN; PNEUMONIA; PROTEIN BLOOD LEVEL; SURFACE AREA; SYSTEMIC DISEASE; ANIMAL; GENETICS; METABOLISM; PATHOLOGY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTOR; TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEIN E3; LIPOPOLYSACCHARIDES; MICE; MICE, TRANSGENIC; PLAQUE, ATHEROSCLEROTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS;

EID: 85056510159     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000001026     Document Type: Article

References (35)

1. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P: Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351(25):2611-2618, 2004.
2. Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H: Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 351(9114):1467-1471, 1998.
3. Elkind MS, Carty CL, O'Meara ES, Lumley T, Lefkowitz D, Kronmal RA, Longstreth WT: Jr.: Hospitalization for infection and risk of acute ischemic stroke: the Cardiovascular Health Study. Stroke 42(7):1851-1856, 2011.
4. Lalmohamed A, Vestergaard P, Klop C, Grove EL, de Boer A, Leufkens HG, van Staa TP, de Vries F: Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort study. Arch Intern Med 172(16):1229-1235, 2012.
5. Cohen MC, Aretz TH: Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol 8(3):133-139, 1999.
6. Corrales-Medina VF, Madjid M, Musher DM: Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 10(2):83-92, 2010.
7. Madjid M, Vela D, Khalili-Tabrizi H, Casscells SW, Litovsky S: Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes. Tex Heart Inst J 34(1):11-18, 2007.
8. Virmani R, Burke AP, Farb A, Kolodgie FD: Pathology of the vulnerable plaque. J Am Coll Cardiol 47(8 suppl):C13-C18, 2006.
9. Libby P: Inflammation in atherosclerosis. Nature 420(6917):868-874, 2002.
10. Santos-Gallego CG, Picatoste B, Badimon JJ: Pathophysiology of acute coronary syndrome. Curr Atheroscler Rep 16(4):401, 2014.
11. Thompson JC, Jayne C, Thompson J, Wilson PG, Yoder MH, Webb N, Tannock LR: A brief elevation of serum amyloid A is sufficient to increase atherosclerosis. J Lipid Res 56(2):286-293, 2015.
12. Kaynar AM, Yende S, Zhu L, Frederick DR, Chambers R, Burton CL, Carter M, Stolz DB, Agostini B, Gregory AD, et al.: Effects of intra-abdominal sepsis on atherosclerosis in mice. Crit Care 18(5):469, 2014.
13. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 15(9):1512-1531, 1995.
14. Morrison M, van der Heijden R, Heeringa P, Kaijzel E, Verschuren L, Blomhoff R, Kooistra T, Kleemann R: Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFkappaB in vivo. Atherosclerosis 233(1):149-156, 2014.
15. Burkholder T, Foltz C, Karlsson E, Linton CG, Smith JM: Health evaluation of experimental laboratory mice. Curr Protoc Mouse Biol 2:145-165, 2012.
16. Kleemann R, Zadelaar S, Kooistra T: Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 79(3):360-376, 2008.
17. Zhang N, Ahsan MH, Purchio AF, West DB: Serum amyloid A-luciferase transgenic mice: response to sepsis, acute arthritis, and contact hypersensitivity and the effects of proteasome inhibition. J Immunol 174(12):8125-8134, 2005.
18. King VL, Thompson J, Tannock LR: Serum amyloid A in atherosclerosis. Curr Opin Lipidol 22(4):302-307, 2011.
19. Naghavi M, Wyde P, Litovsky S, Madjid M, Akhtar A, Naguib S, Siadaty MS, Sanati S, Casscells W: Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 107(5):762-768, 2003.
20. Dyson A, Singer M: Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit Care Med 37(1 suppl):S30-S37, 2009.
21. Dejager L, Pinheiro I, Dejonckheere E, Libert C: Cecal ligation and puncture: the gold standard model for polymicrobial sepsis? Trends Microbiol 19(4):198-208, 2011.
22. Remick DG, Newcomb DE, Bolgos GL, Call DR: Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13(2):110-116, 2000.
23. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock-a review of laboratory models and a proposal. J Surg Res 29(2):189-201, 1980.
24. Maier S, Traeger T, Entleutner M, Westerholt A, Kleist B, Huser N, Holzmann B, Stier A, Pfeffer K, Heidecke CD: Cecal ligation and puncture versus colon ascendens stent peritonitis: two distinct animal models for polymicrobial sepsis. Shock 21(6):505-511, 2004.
25. Virmani R, Burke AP, Kolodgie FD, Farb A: Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol 15(6):439-446, 2002.
26. Tabas I: Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 10(1):36-46, 2010.
27. Fuijkschot WW, Morrison MC, van der Linden R, Krijnen PA, Zethof IP, Theyse LF, Kleemann R, Niessen HW, Smulders YM: Orthopedic surgery increases atherosclerotic lesions and necrotic core area in ApoE-/- mice. Atherosclerosis 255:164-170, 2016.
28. Gijbels MJ, van der Cammen M, van der Laan LJ, Emeis JJ, Havekes LM, Hofker MH, Kraal G: Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study. Atherosclerosis 143(1):15-25, 1999.
29. Zadelaar S, Kleemann R, Verschuren L, de Vries-Van der Weij J, van der Hoorn J, Princen HM, Kooistra T: Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol 27(8):1706-1721, 2007.
30. Madenspacher JH, Azzam KM, Gong W, Gowdy KM, Vitek MP, Laskowitz DT, Remaley AT, Wang JM, Fessler MB: Apolipoproteins and apolipoprotein mimetic peptides modulate phagocyte trafficking through chemotactic activity. J Biol Chem 287(52):43730-43740, 2012.
31. Rensen PC, Oosten M, Bilt E, Eck M, Kuiper J, Berkel TJ: Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo. J Clin Invest 99(10):2438-2445, 1997.
32. Laskowitz DT, Lee DM, Schmechel D, Staats HF: Altered immune responses in apolipoprotein E-deficient mice. J Lipid Res 41(4):613-620, 2000.
33. Kattan OM, Kasravi FB, Elford EL, Schell MT, Harris HW: Apolipoprotein E-mediated immune regulation in sepsis. J Immunol 181(2):1399-1408, 2008.
34. Chen YC, Bui AV, Diesch J, Manasseh R, Hausding C, Rivera J, Haviv I, Agrotis A, Htun NM, Jowett J, et al.: A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling. Circ Res 113(3):252-265, 2013.
35. Van der Donckt C, Van Herck JL, Schrijvers DM, Vanhoutte G, Verhoye M, Blockx I, Van Der Linden A, Bauters D, Lijnen HR, Sluimer JC, et al.: Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death. Eur Heart J 36(17):1049-1058, 2015.